Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,744,265
+$124,606 QoQ
Shares Held
6,868
+3.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#2,474
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SAGE RHINO CAPITAL LLC holds $11,215,095 across 12 Drug Manufacturers - General names. JNJ ranks #2 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,014 | $2,415,652 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
6,868 | $1,744,265 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,448 | $1,342,568 | |
| 4 | NVS |
Novartis AG
|
7,947 | $1,245,453 | |
| 5 | AZN |
Astrazeneca PLC
|
5,336 | $1,011,812 | |
| 6 | AMGN |
Amgen Inc
|
2,387 | $864,380 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
5,127 | $647,745 | |
| 8 | ABBV |
AbbVie Inc.
|
2,265 | $569,964 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,744,265 | 6,868 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,619,659 | 6,626 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,415,744 | 6,841 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,281,252 | 6,910 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,050,614 | 6,878 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,116,932 | 6,735 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $979,366 | 6,772 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,115,134 | 6,881 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,021,366 | 6,988 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,112,866 | 7,035 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $1,087,775 | 6,940 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,084,487 | 6,963 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $1,156,984 | 6,990 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,081,435 | 6,977 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $1,271,173 | 7,196 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $1,168,024 | 7,150 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,284,284 | 7,235 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,275,878 | 7,199 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $1,228,795 | 7,183 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,135,022 | 7,028 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $1,155,156 | 7,012 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $1,135,822 | 6,911 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,053,659 | 6,695 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $986,032 | 6,623 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $930,829 | 6,619 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $849,722 | 6,480 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||